Page results
-
The Maternal Medicine team provides care for women with pre-existing medical disorders or pregnancy-related medical conditions. We work in a multidisciplinary team of doctors and midwives in order to provide the best standard of care for women and their babies.
-
This page provides information about different medicines that might help to relieve neuropathic pain.
-
Professor Lunn's specialist clinical and research interests are in the inflammatory neuropathies, particularly Guillain-Barré syndrome, CIDP and paraproteinaemic neuropathies.
-
This has been written by the Adult Allergy Clinic team at the Royal London Hospital for Integrated Medicine. It is intended for patients (or their family or carers) who may be referred to this clinic.
-
UCLH has recruited the first participant in Europe to a global clinical trial for adults with Myotonic Dystrophy Type 1 (DM1)- a genetic condition and type of muscular dystrophy that causes progressive muscle weakness and wasting.
-
The Teenage and Young Adults Cancer Service looks after people aged from 13 to 24, who may have a wide range of cancers and some non-cancerous conditions.
-
C. diff is a bacterium (a “bug”) that lives harmlessly in the bowel (gut) of approximately three per cent of people. If the balance of C. diff and good bacteria is disrupted (for example when taking antibiotics), the good bacteria may be killed and C. diff can multiply and produce toxins. These toxins cause inflammation in the bowel and diarrhoea.
-
The Unit’s research strategy is clinical and patient-centred, with the primary objective being to further improve the outcome and the quality of life of patients, and to advance surgical therapies for patients with pituitary and central skull base disease.
-
Nausea and vomiting (NVP) affects up to 80% of pregnant women in the first trimester.
-
The aim of this page is to provide you with information about flow-diverting stents and how they are used to treat cerebral (brain) aneurysms.
File results
-
FOI/2022/0048 - Cancer deaths in relation to Covid-19
-
FOI/2022/0069 - Trust’s flexible endoscope inventory
-
FOI/2022/0094 - Emergency Covid funding - private FM contractors
-
FOI/2022/0114 - Number of new diagnoses relating to various conditions
-
FOI/2022/0118 - Contact centre/ Call centre contracts
-
FOI/2022/0150 - Hepatocellular carcinoma drug treatments
-
FOI/2022/0161 - Referral to treatment waiting times
-
FOI/2022/0163 - Ongoing staff absence due to COVID-19
-
FOI/2022/0166 - Routine GP referrals made to Cardiology, Gynaecology and Neurology
-
FOI/2022/0171 - Consultant-led Referral to Treatment (RTT), outpatients and Patient Initiated Follow-up (PIFU)